PDRadiopharma to Present at ESRAH 2026 (13th Educational Symposium on Radiation and Health by Young Scientists)

PDRadiopharma announces that its President and CEO, Masato Murakami, will deliver a presentation at ESRAH 2026 titled:
“Building the Future of Radiopharmaceuticals: Peptide Discovery, Theranostics and Translation to Patient Care.”

The continued advancement of radiopharmaceuticals requires collaboration across research fields and scientific disciplines. Through participation in this symposium, PDR Pharma aims to foster the exchange of knowledge with young scientists, contribute to the creation of new possibilities in radiopharmaceuticals, and help deliver greater value to patients.